![Fabian Walesch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fabian Walesch
Private Equity Investor at PREMIUM Equity Partners GmbH
Profile
Fabian Walesch is currently a Partner at PREMIUM Equity Partners GmbH since 2015.
Prior to his current position, he worked as a Senior Investment Manager at Cross Equity Partners AG from 2014 to 2015.
He also worked as an Investment Manager at Halder Beteiligungsberatung GmbH from 2005 to 2011.
Mr. Walesch was a Director at Micro-Macinazione SA.
Fabian Walesch active positions
Companies | Position | Start |
---|---|---|
PREMIUM Equity Partners GmbH
![]() PREMIUM Equity Partners GmbH Investment ManagersFinance PREMIUM Equity Partners GmbH (PREMIUM) is an independent private equity firm founded by Marcel Van Wijk and Dr. Thomas Duhnkrack in 2011. The firm is headquartered in Frankfurt, Germany. | Private Equity Investor | 2015-06-30 |
Former positions of Fabian Walesch
Companies | Position | End |
---|---|---|
Cross Equity Partners AG
![]() Cross Equity Partners AG Investment ManagersFinance Cross Equity Partners AG (Cross) is an independent private equity firm headquartered in Pfäffikon, Switzerland. The firm was founded in 2008. | Private Equity Investor | 2015-06-29 |
Halder Beteiligungsberatung GmbH
![]() Halder Beteiligungsberatung GmbH Investment ManagersFinance Halder Beteiligungsberatung GmbH (HB) is an independent German private equity firm which was established in 1991. Based in Frankfurt, HB provides mid-sized firms with equity capital in Germany, the Netherlands and Belgium. The firm's investors include funds of funds, insurance companies, banks, corporations and pension funds. | Private Equity Investor | 2011-08-31 |
Micro-Macinazione SA
![]() Micro-Macinazione SA Pharmaceuticals: MajorHealth Technology Micro-Macinazione SA provides micronization technologies and services for the pharmaceutical and fine chemical industry. The firm offers services for the micronization of bulk active pharmaceutical ingredients and also designs and produces jet spiral jet mills, isolated jet mills, cosmetic jet mills, isolators, feeders, cryogenic exchangers and ancillary equipment which are used in the micronization process. The company was founded in 1970 and is headquartered in Molinazzo di Monteggio, Switzerland. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Halder Beteiligungsberatung GmbH
![]() Halder Beteiligungsberatung GmbH Investment ManagersFinance Halder Beteiligungsberatung GmbH (HB) is an independent German private equity firm which was established in 1991. Based in Frankfurt, HB provides mid-sized firms with equity capital in Germany, the Netherlands and Belgium. The firm's investors include funds of funds, insurance companies, banks, corporations and pension funds. | Finance |
Cross Equity Partners AG
![]() Cross Equity Partners AG Investment ManagersFinance Cross Equity Partners AG (Cross) is an independent private equity firm headquartered in Pfäffikon, Switzerland. The firm was founded in 2008. | Finance |
PREMIUM Equity Partners GmbH
![]() PREMIUM Equity Partners GmbH Investment ManagersFinance PREMIUM Equity Partners GmbH (PREMIUM) is an independent private equity firm founded by Marcel Van Wijk and Dr. Thomas Duhnkrack in 2011. The firm is headquartered in Frankfurt, Germany. | Finance |
Micro-Macinazione SA
![]() Micro-Macinazione SA Pharmaceuticals: MajorHealth Technology Micro-Macinazione SA provides micronization technologies and services for the pharmaceutical and fine chemical industry. The firm offers services for the micronization of bulk active pharmaceutical ingredients and also designs and produces jet spiral jet mills, isolated jet mills, cosmetic jet mills, isolators, feeders, cryogenic exchangers and ancillary equipment which are used in the micronization process. The company was founded in 1970 and is headquartered in Molinazzo di Monteggio, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Fabian Walesch